CRSP — Crispr Therapeutics AG Share News
0.000.00%
Last trade - 00:00- $4.98bn
- $3.20bn
- $3.51m
Swiss stocks - Factors to watch on August 4
Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansion
Swiss stocks - Factors to watch on August 3
Gene-editing firm CRISPR steadies after boosted $550 mln convertible debt deal
Brief: CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Gene-editing co CRISPR falls after unveiling $350 mln convertible debt deal
Vertex's gene therapy shows promise in younger children with blood disorders
U.S. RESEARCH ROUNDUP-Alibaba, Kroger, Oscar Health
CRISPR rises after experimental therapy cuts harmful cholesterol levels by half in small study
CRISPR gene therapy slashes 'bad' cholesterol, triglycerides by half in small study
Brief: Crispr Therapeutics May Offer & Sell Common Shares Of Up To $600 Million From Time To Time
Crispr Therapeutics falls after weak quarterly results
Gene therapy makers rise after US FDA's chief medical and science officer departs
Gene therapy makers rise after US FDA's chief medical and science officer departs
Brief: Crispr Therapeutics Reports Positive Additional Phase 1 Data For Ctx310™ Targeting Angptl3 And Provides Update On In Vivo Cardiovascular Pipeline
Gene-editing firms rise after Lilly strikes deal to acquire Verve Therapeutics
Brief: Crispr Therapeutics And Sirius Therapeutics Announce Multi-Target Collaboration To Develop Novel Sirna Therapies
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official